CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's EPS Net Growth by Quarter and Year

Atara Biotherapeutics Inc 's EPS Net results by quarter and year




ATRA EPS Net (in $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December -1.37 -1.74 -1.15 -0.63
III Quarter September -1.31 -1.29 -1.02 -0.88
II Quarter June -1.60 -1.15 -0.94 -0.66
I Quarter March -1.44 -1.05 -0.88 -0.58
FY   -5.72 -5.23 -3.99 -2.75



ATRA EPS Net forth quarter 2018 Y/Y Growth Comment
Atara Biotherapeutics Inc in the forth quarter recorded EPS net loss of $ -1.37 .

According to the results reported in the forth quarter, Atara Biotherapeutics Inc achieved the best EPS Net growth in Biotechnology & Drugs industry. While Atara Biotherapeutics Inc ' s EPS Net no change of % ranks overall at the positon no. in the forth quarter.




ATRA EPS Net ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics Inc 's forth quarter 2018 EPS Net $ -1.37 ATRA's Income Statement
Atara Biotherapeutics Inc 's forth quarter 2017 EPS Net $ -1.74 Quarterly ATRA's Income Statement
New: More ATRA's historic EPS Net Growth >>


ATRA EPS Net (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net forth quarter 2018 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Atara Biotherapeutics Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q EPS Net Comment
Current EPS net loss of -1.37 by Atara Biotherapeutics Inc appear even more unfavourable compare to the -1.31 in the third quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential EPS Net growth. While Atara Biotherapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q EPS Net Comment
Recent EPS net loss of -1.37 by Atara Biotherapeutics Inc come out even more unfavourable considering the EPS net loss -1.31 in the previous quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential EPS Net growth. While Atara Biotherapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


Atara Biotherapeutics Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
Cumulative EPS Net 12 Months Ending $ -6.15 $ -6.09 $ -6.07 $ 0.00 $ 0.00
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Atara Biotherapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -6 in the Dec 31 2019 period.
The situation is worsening as the cumulative EPS net loss is becoming larger from $ -6.07 in the twelve months ending a quarter before and $ -1.31 for the twelve months ending in the quarter .

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Atara Biotherapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -6 in the Dec 31 2019 period.
The results are getting worse as the cumulative EPS net loss is becoming larger from $ -6.07 in TTM ending quarter Sep 30 2019 and $ -1.31 for the twelve months ending in the quarter Kabir Chauhan  told.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
ATRA's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for ATRA's Competitors
EPS Net Growth for Atara Biotherapeutics Inc 's Suppliers
EPS Net Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Dec 31 2019
Zoetis Inc -2.97 %$ -2.966 
Bruker Corporation -4.87 %$ -4.873 
Amgen Inc -5.47 %$ -5.466 
Novartis Ag -5.95 %$ -5.948 
Conmed Corporation -6.08 %$ -6.085 
Collegium Pharmaceutical Inc -6.44 %$ -6.445 
Petmed Express Inc -10.53 %$ -10.526 
Vascular Biogenics Ltd -12.90 %$ -12.903 
Fonar Corp -13.73 %$ -13.725 
Acorda Therapeutics inc -15.40 %$ -15.398 
United Therapeutics Corporation -17.86 %$ -17.856 
Phibro Animal Health Corp -19.44 %$ -19.444 
Regeneron Pharmaceuticals Inc -20.95 %$ -20.952 
Lemaitre Vascular Inc -21.63 %$ -21.635 
Cyclacel Pharmaceuticals Inc -21.74 %$ -21.739 
Kitov Pharma Ltd -23.08 %$ -23.077 
Antares Pharma Inc -26.07 %$ -26.067 
Trillium Therapeutics Inc -29.61 %$ -29.606 
Catalent Inc -30.30 %$ -30.303 
Fresenius Medical Care Ag & Co. Kgaa -31.24 %$ -31.237 
Check cap Ltd -33.72 %$ -33.716 
National Healthcare Corp -34.52 %$ -34.521 
Sanofi -34.99 %$ -34.985 
Align Technology inc -36.98 %$ -36.985 
Cyanotech Corp -40.00 %$ -40.000 
Integra Lifesciences Holdings Corp -40.05 %$ -40.048 
Alpha Pro Tech Ltd -43.37 %$ -43.369 
Ionis Pharmaceuticals Inc -45.31 %$ -45.309 
Enanta Pharmaceuticals Inc -48.00 %$ -48.000 
Insulet Corporation -50.00 %$ -50.000 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CBMB's Profile

Stock Price

CBMB's Financials

Business Description

Fundamentals

Charts & Quotes

CBMB's News

Suppliers

CBMB's Competitors

Customers & Markets

Economic Indicators

CBMB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071